• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

神经元特异性烯醇化酶和tau蛋白作为神经元损伤的神经生化标志物,与急性缺血性卒中的早期临床病程及长期预后相关。

Neuron-specific enolase and tau protein as neurobiochemical markers of neuronal damage are related to early clinical course and long-term outcome in acute ischemic stroke.

作者信息

Wunderlich Michael T, Lins Hartmut, Skalej Martin, Wallesch Claus-W, Goertler Michael

机构信息

Department of Neurology, Otto-von-Guericke-University of Magdeburg, Leipziger Strasse 44, 39120 Magdeburg, Germany.

出版信息

Clin Neurol Neurosurg. 2006 Sep;108(6):558-63. doi: 10.1016/j.clineuro.2005.12.006. Epub 2006 Feb 2.

DOI:10.1016/j.clineuro.2005.12.006
PMID:16457947
Abstract

OBJECTIVES

Analyses of neuron-specific enolase (NSE) and tau protein in patients with hyperacute ischemic stroke, their association with infarct volume, severity of the neurological deficit, the neurovascular status and functional outcome.

PATIENTS AND METHODS

In 66 consecutive patients, serial venous blood samples were taken at 3, 6, 12, 18, 24, 48, 72, 96, and 120 h after stroke onset. The neurovascular status was assessed by repetitive extra- and transcranial duplex sonography. Neurological deficits were quantified by the NIH stroke scale, and functional outcome was assessed with the modified Rankin scale (mRS).

RESULTS

After a first rise within 3 h, NSE decreased followed by a secondary increase until Day 5. Tau protein concentrations showed a continuous increase from admission onward. NSE and tau release were highly correlated with severity of neurological deficits and infarct volume (P = 0.001). NSE, but not tau protein, release was associated to the neurovascular status on admission. NSE and tau protein values were significantly correlated with the functional outcome at 3 months (P < 0.001).

CONCLUSION

Release kinetics of NSE and tau protein are associated with patients' clinical deficits and infarct volume, and may be used as an additional predictor of the early course and functional outcome.

摘要

目的

分析超急性缺血性脑卒中患者的神经元特异性烯醇化酶(NSE)和tau蛋白,及其与梗死体积、神经功能缺损严重程度、神经血管状态和功能转归的关系。

患者与方法

连续纳入66例患者,在卒中发作后3、6、12、18、24、48、72、96和120小时采集系列静脉血样本。通过重复的颅外和经颅双功超声评估神经血管状态。用美国国立卫生研究院卒中量表对神经功能缺损进行量化,并用改良Rankin量表(mRS)评估功能转归。

结果

NSE在3小时内首次升高后下降,随后在第5天出现二次升高。tau蛋白浓度自入院起持续升高。NSE和tau释放与神经功能缺损严重程度和梗死体积高度相关(P = 0.001)。NSE释放与入院时的神经血管状态相关,而tau蛋白则不然。NSE和tau蛋白值与3个月时的功能转归显著相关(P < 0.001)。

结论

NSE和tau蛋白的释放动力学与患者的临床缺损和梗死体积相关,可作为早期病程和功能转归的额外预测指标。

相似文献

1
Neuron-specific enolase and tau protein as neurobiochemical markers of neuronal damage are related to early clinical course and long-term outcome in acute ischemic stroke.神经元特异性烯醇化酶和tau蛋白作为神经元损伤的神经生化标志物,与急性缺血性卒中的早期临床病程及长期预后相关。
Clin Neurol Neurosurg. 2006 Sep;108(6):558-63. doi: 10.1016/j.clineuro.2005.12.006. Epub 2006 Feb 2.
2
Release of neurobiochemical markers of brain damage is related to the neurovascular status on admission and the site of arterial occlusion in acute ischemic stroke.脑损伤神经生化标志物的释放与急性缺血性卒中入院时的神经血管状况及动脉闭塞部位有关。
J Neurol Sci. 2004 Dec 15;227(1):49-53. doi: 10.1016/j.jns.2004.08.005.
3
Serum S-100B is superior to neuron-specific enolase as an early prognostic biomarker for neurological outcome following cardiopulmonary resuscitation.血清S-100B作为心肺复苏后神经功能预后的早期预后生物标志物优于神经元特异性烯醇化酶。
Resuscitation. 2009 Aug;80(8):870-5. doi: 10.1016/j.resuscitation.2009.05.005. Epub 2009 Jun 17.
4
[Serum S-100B protein and neuron-specific enolase after traumatic brain injury].创伤性脑损伤后的血清S-100B蛋白和神经元特异性烯醇化酶
No Shinkei Geka. 2005 Nov;33(11):1073-80.
5
Prognostic value of neuron specific enolase and IL-10 in ischemic stroke and its correlation with degree of neurological deficit.神经元特异性烯醇化酶和白细胞介素-10 在缺血性脑卒中的预后价值及其与神经功能缺损程度的相关性。
Clin Chim Acta. 2013 Apr 18;419:136-8. doi: 10.1016/j.cca.2013.02.014. Epub 2013 Feb 21.
6
Neuron-specific enolase as a marker of the severity and outcome of hypoxic ischemic encephalopathy.神经元特异性烯醇化酶作为缺氧缺血性脑病严重程度及预后的标志物。
Brain Dev. 2004 Sep;26(6):398-402. doi: 10.1016/j.braindev.2003.12.007.
7
Neuron-specific enolase in patients with acute ischemic stroke and related dementia.急性缺血性中风及相关痴呆患者的神经元特异性烯醇化酶
Chin Med J (Engl). 1995 Mar;108(3):221-3.
8
[Neuro-specific enolase in acute ischemic stroke and related dementia patients].[急性缺血性脑卒中及相关痴呆患者中的神经特异性烯醇化酶]
Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 1995 Dec;17(6):439-42.
9
Clinical, biochemical and neuroimaging parameters after thrombolytic therapy predict long-term stroke outcome.溶栓治疗后的临床、生化和神经影像学参数可预测长期卒中结局。
Eur Neurol. 2009;62(1):9-15. doi: 10.1159/000215876. Epub 2009 Apr 30.
10
Are serum S100beta proteins and neuron-specific enolase predictors of cerebral damage in cardiovascular surgery?血清S100β蛋白和神经元特异性烯醇化酶是心血管手术中脑损伤的预测指标吗?
J Cardiothorac Vasc Anesth. 2003 Feb;17(1):4-9. doi: 10.1053/jcan.2003.2.

引用本文的文献

1
Plasma Profiles of Neuroglial Injury Biomarkers after Ischemic Stroke.缺血性中风后神经胶质损伤生物标志物的血浆概况
Transl Stroke Res. 2025 Sep 3. doi: 10.1007/s12975-025-01380-y.
2
Plasma brain-derived tau correlates with cerebral infarct volume.血浆中脑源性tau蛋白与脑梗死体积相关。
J Intern Med. 2025 Feb;297(2):173-185. doi: 10.1111/joim.20041. Epub 2024 Dec 5.
3
Neuron-specific enolase as a prognostic biomarker in acute ischemic stroke patients treated with reperfusion therapies.神经元特异性烯醇化酶作为接受再灌注治疗的急性缺血性脑卒中患者的预后生物标志物。
Front Neurol. 2024 Jul 18;15:1408111. doi: 10.3389/fneur.2024.1408111. eCollection 2024.
4
Electrical impedance tomography provides information of brain injury during total aortic arch replacement through its correlation with relative difference of neurological biomarkers.通过与神经生物标志物的相对差异相关联,电阻抗断层成像术为全主动脉弓置换术期间的脑损伤提供了信息。
Sci Rep. 2024 Jun 20;14(1):14236. doi: 10.1038/s41598-024-65203-0.
5
Neuron-specific enolase at admission as a predictor for stroke volume, severity and outcome in ischemic stroke patients: a prognostic biomarker review.入院时神经元特异性烯醇化酶作为预测缺血性脑卒中患者的卒中量、严重程度和结局的预后生物标志物的研究进展。
Sci Rep. 2024 Feb 1;14(1):2688. doi: 10.1038/s41598-024-53080-6.
6
Comparative analysis of hippocampal extracellular space uncovers widely altered peptidome upon epileptic seizure in urethane-anaesthetized rats.比较分析海马细胞外空间揭示了在乌拉坦麻醉大鼠癫痫发作时广泛改变的肽组。
Fluids Barriers CNS. 2024 Jan 11;21(1):6. doi: 10.1186/s12987-024-00508-w.
7
Concordance between the In Vivo Content of Neurospecific Proteins (BDNF, NSE, VILIP-1, S100B) in the Hippocampus and Blood in Patients with Epilepsy.海马神经特异性蛋白(BDNF、NSE、VILIP-1、S100B)在癫痫患者体内的含量与血液中的含量具有一致性。
Int J Mol Sci. 2023 Dec 29;25(1):502. doi: 10.3390/ijms25010502.
8
Cerebrospinal Fluid and Serum Biomarker Insights in Aneurysmal Subarachnoid Haemorrhage: Navigating the Brain-Heart Interrelationship for Improved Patient Outcomes.动脉瘤性蛛网膜下腔出血中的脑脊液和血清生物标志物见解:探索脑心相互关系以改善患者预后
Biomedicines. 2023 Oct 19;11(10):2835. doi: 10.3390/biomedicines11102835.
9
Blood-Based Biomarkers for Neuroprognostication in Acute Brain Injury.基于血液的生物标志物在急性脑损伤中的神经预后评估。
Semin Neurol. 2023 Oct;43(5):689-698. doi: 10.1055/s-0043-1775764. Epub 2023 Sep 26.
10
Secondary neurodegeneration following Stroke: what can blood biomarkers tell us?中风后的继发性神经退行性变:血液生物标志物能告诉我们什么?
Front Neurol. 2023 Sep 1;14:1198216. doi: 10.3389/fneur.2023.1198216. eCollection 2023.